Table 2

Proportion and cumulative recovery of each metabolite in bile after intravenous administration of ¹⁴C-VPA at 30 mg/kg, with or without PAPM treatment

	Proportion of each metabolite in bile ^2-a		Cumulative recovery
	VPA alone	PAPM treatment	VPA alone	PAPM treatment
	TLC %		% of Dose
VPA	2.7 ± 1.2 ^2-b	1.6 ± 1.0	1.1 ± 0.5	0.9 ± 0.6
BM-2	3.9 ± 0.6	4.2 ± 2.6	1.7 ± 0.3	2.4 ± 1.5
VPA glucuronide	89.4 ± 1.5	90.6 ± 4.7	38.3 ± 0.7	52.5 ± 2.7
BM-1	2.9 ± 0.8	2.6 ± 0.6	1.3 ± 0.4	1.5 ± 0.4
n^2-c	3	5	3	5